ARYD · Arya Sciences Acquisition Corp IV - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $611.7K | - | $959.7K | $78.9K | $968.6K | - | $180.4K | $304.8K | $252.7K | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($611.7K) | - | ($959.7K) | ($78.9K) | ($968.6K) | - | ($180.4K) | ($304.8K) | ($252.7K) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($245.8K) | - | ($455.1K) | $381.5K | $160.2K | - | $3.18M | ($196.0K) | ($211.2K) | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $87.5K | $20.2K | $13.8K | $18.0K | $60.0K | $91.0K | $23.1K | $49.5K | $379.4K | $501.2K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $157.8K | $130.5K | $89.3K | $79.6K | $68.8K | $65.9K | $67.1K | $67.1K | $228.9K | $173.1K |
| Current Assets | $140.9K | $76.7K | $171.4K | $282.0K | $114.2K | $146.4K | $174.0K | $295.9K | $721.3K | $870.0K |
| Total Assets | $37.26M | $40.65M | $39.80M | $38.99M | $38.22M | $151.78M | $150.62M | $150.00M | $150.32M | $150.42M |
| Current Liabilities | $12.15M | $12.35M | $9.28M | $8.01M | $7.63M | $6.27M | $6.03M | $5.97M | $6.09M | $5.99M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $14.76M | $14.97M | $11.90M | $10.63M | $10.24M | $8.89M | $8.64M | $11.20M | $11.32M | $11.22M |
| Stockholders' Equity | ($14.52M) | ($14.79M) | ($11.63M) | ($10.25M) | ($10.03M) | ($8.64M) | ($8.37M) | ($10.81M) | ($10.51M) | ($10.30M) |
| Retained Earnings | ($15.04M) | ($14.79M) | ($11.63M) | ($10.25M) | ($10.03M) | ($8.64M) | ($8.37M) | ($10.81M) | ($10.51M) | ($10.30M) |
Cash Flow
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($511.7K) | - | - | - | ($211.0K) | - | - | - | ($76.9K) | - |
| Investing Cash Flow | $3.97M | - | - | - | $114.65M | - | - | - | $0 | - |
| Financing Cash Flow | ($3.39M) | - | - | - | ($114.47M) | - | - | - | ($45.0K) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -0.7% | - | -1.1% | 1.0% | 0.4% | - | 2.1% | -0.1% | -0.1% | - |
| Return on equity | 1.7% | - | 3.9% | -3.7% | -1.6% | - | -38.0% | 1.8% | 2.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.01 | 0.01 | 0.02 | 0.04 | 0.01 | 0.02 | 0.03 | 0.05 | 0.12 | 0.15 |
| Quick ratio | 0.01 | 0.01 | 0.02 | 0.04 | 0.01 | 0.02 | 0.03 | 0.05 | 0.12 | 0.15 |
| Cash ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.06 | 0.08 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | -2.57 | -2.75 | -3.42 | -3.80 | -3.81 | -17.57 | -18.00 | -13.88 | -14.31 | -14.61 |
| Liabilities / Assets | 0.40 | 0.37 | 0.30 | 0.27 | 0.27 | 0.06 | 0.06 | 0.07 | 0.08 | 0.07 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 36.8% | - | -432.0% | 74.1% | -283.3% | - | 96.5% | -82.6% | -12.0% | - |
| Net income growth (YoY) | - | - | - | - | - | - | - | -20.7% | -0.4% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -44.8% | -71.2% | -38.9% | 5.2% | 4.5% | 16.1% | - | - | -77501.7% | - |
Peer comparison
Same SIC group: Blank Checks
Comparing ARYA Sciences Acquisition Corp IV against the 5 most active filers in the same SIC group.